Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
NCT05606471
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes Mellitus in Obese
Interventions
DRUG:
Semaglutide Pen Injector [Ozempic]
DIETARY_SUPPLEMENT:
Very-low Calorie Diet
Sponsor
University of Nottingham
Collaborators
[object Object]